Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral: Vanier Canada Graduate Scholarships

University of Calgary

$150,000.00

Rejuvenating Macrophages/Microglia for Remyelination in Aging Mice

EF 2013-14

Résumé
Normal aging impairs remyelination, the process of restoring the protective myelin sheath to the nerves. This age-related impairment may be one of several reasons underlying the absence of recovery in many neurodegenerative diseases, including multiple sclerosis, Alzheimer's disease, stroke, and spinal cord injury. From studies carried out on aging rodents, the impairment in remyelination is thought to be due to a decrease in the beneficial activity of a subset of immune cells called macrophages and microglia. In this project, we will use a mouse model of remyelination to understand why the decreased activity of these immune cells are impairing remyelination in aging mice. We will then determine the mechanism underlying the decreased activity of these immune cells. We will then use five clinically-approved compounds which increase the activity of these immune cells to test whether remyelination can be improved in aging mice. This study may provide new potential therapies for Canadians suffering from neurodegenerative diseases.
Programme
Doctoral: Vanier Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
299136
Name
Rawji Khalil
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Rejuvenating Macrophages/Microglia for Remyelination in Aging Mice
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Bumetanide; Chondroitin Sulfate Proteoglycans; Demyelination; Lysolecithin Demyelination; Macrophages; Microglia; Multiple Sclerosis; Niacin; Oligodendrocytes; Remyelination
Abstract
Normal aging impairs remyelination, the process of restoring the protective myelin sheath to the nerves. This age-related impairment may be one of several reasons underlying the absence of recovery in many neurodegenerative diseases, including multiple sclerosis, Alzheimer's disease, stroke, and spinal cord injury. From studies carried out on aging rodents, the impairment in remyelination is thought to be due to a decrease in the beneficial activity of a subset of immune cells called macrophages and microglia. In this project, we will use a mouse model of remyelination to understand why the decreased activity of these immune cells are impairing remyelination in aging mice. We will then determine the mechanism underlying the decreased activity of these immune cells. We will then use five clinically-approved compounds which increase the activity of these immune cells to test whether remyelination can be improved in aging mice. This study may provide new potential therapies for Canadians suffering from neurodegenerative diseases.
Competitiondate
201311
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Rawji, Khalil
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~